Literature DB >> 18054062

Persistent transcription of a nonintegrating mutant of simian immunodeficiency virus in rhesus macrophages.

Yanfang Zheng1, Ilnour Ourmanov, Vanessa M Hirsch.   

Abstract

A nonintegrating mutant, SIVsmD116N, was derived from the infectious pathogenic SIVsmE543-3 clone by introducing an Asp (D) to Asn (N) mutation into the catalytic domain of integrase. Although SIVsmD116N generated all viral proteins following transfection, cell-free virus did not productively infect CEMx174 cells, macaque peripheral blood mononuclear cells (PBMCs) or monocyte-derived macrophages (MDM). Viral DNA and transcripts were observed transiently in SIVsmD116N-infected CEMx174 cells and macaque PBMC but persisted in MDM for as long as 20 days. Circular forms of viral DNA were detected but there was no evidence of integration detected by Alu PCR. We found that SIV D116N mutant remained transcriptionally active and expressed low levels of viral proteins persistently in MDM. These data are consistent with a role for macrophages as a persistent latent reservoir for AIDS viruses. The capacity of nonintegrating SIV to persistently generate viral products in macrophages suggests that nonintegrating lentiviral vectors could be engineered to efficiently and safely express proteins for vaccine purposes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054062      PMCID: PMC2350229          DOI: 10.1016/j.virol.2007.11.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

2.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

3.  Antibodies that neutralize SIV(mac)251 in T lymphocytes cause interruption of the viral life cycle in macrophages by preventing nuclear import of viral DNA.

Authors:  W Zhuge; F Jia; G Mackay; A Kumar; O Narayan
Journal:  Virology       Date:  2001-09-01       Impact factor: 3.616

4.  Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA.

Authors:  A Cara; J Vargas; M Keller; S Jones; A Mosoian; A Gurtman; A Cohen; V Parkas; F Wallach; E Chusid; I H Gelman; M E Klotman
Journal:  Virology       Date:  2002-01-05       Impact factor: 3.616

5.  Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors.

Authors:  Laura Gillim-Ross; Andrea Cara; Mary E Klotman
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

6.  Latent reservoirs of HIV: obstacles to the eradication of virus.

Authors:  T W Chun; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.

Authors:  Y Wu; J W Marsh
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 8.  HIV vaccine development.

Authors:  Mahender Singh; Kuan-Teh Jeang; Stephen M Smith
Journal:  Front Biosci       Date:  2005-09-01

9.  Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

Authors:  M E Sharkey; I Teo; T Greenough; N Sharova; K Luzuriaga; J L Sullivan; R P Bucy; L G Kostrikis; A Haase; C Veryard; R E Davaro; S H Cheeseman; J S Daly; C Bova; R T Ellison; B Mady; K K Lai; G Moyle; M Nelson; B Gazzard; S Shaunak; M Stevenson
Journal:  Nat Med       Date:  2000-01       Impact factor: 87.241

Review 10.  HIV-1 gene expression: lessons from provirus and non-integrated DNA.

Authors:  Yuntao Wu
Journal:  Retrovirology       Date:  2004-06-25       Impact factor: 4.602

View more
  6 in total

1.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells.

Authors:  Donatella R M Negri; Roberta Bona; Zuleika Michelini; Pasqualina Leone; Iole Macchia; Mary E Klotman; Mirella Salvatore; Andrea Cara
Journal:  Hum Gene Ther       Date:  2010-08       Impact factor: 5.695

3.  Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice.

Authors:  Donatella R M Negri; Zuleika Michelini; Silvia Baroncelli; Massimo Spada; Silvia Vendetti; Roberta Bona; Pasqualina Leone; Mary E Klotman; Andrea Cara
Journal:  J Biomed Biotechnol       Date:  2010-05-19

4.  Generation of macrophages from peripheral blood monocytes in the rhesus monkey.

Authors:  Ann E Rozner; Svetlana V Dambaeva; Jessica G Drenzek; Maureen Durning; Thaddeus G Golos
Journal:  J Immunol Methods       Date:  2009-10-08       Impact factor: 2.303

5.  Development and use of SIV-based Integrase defective lentiviral vector for immunization.

Authors:  Zuleika Michelini; Donatella R M Negri; Silvia Baroncelli; Massimo Spada; Pasqualina Leone; Roberta Bona; Mary E Klotman; Andrea Cara
Journal:  Vaccine       Date:  2009-06-11       Impact factor: 3.641

6.  Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine.

Authors:  Chu Wang; Chunlai Jiang; Nan Gao; Kaikai Zhang; Donglai Liu; Wei Wang; Zhe Cong; Chuan Qin; Vitaly V Ganusov; Guido Ferrari; Celia LaBranche; David C Montefiori; Wei Kong; Xianghui Yu; Feng Gao
Journal:  Viruses       Date:  2017-06-02       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.